Clinical trialNCT00807937CompletedPhase 2Interventional

Proof of Concept in Patients With Generalized Anxiety Disorder (GAD)AZD7325

SponsorAstraZenecaEnrollment369Anxiety Disorders

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Mark A. Smith, MD, PhD
AstraZeneca
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

51 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Research Site
Mesa, Arizona, United States
Research Site
Little Rock, Arkansas, United States
Research Site
Carson, California, United States
Research Site
Escondido, California, United States
Research Site
Glendale, California, United States
Research Site
Irvine, California, United States
Research Site
Redlands, California, United States
Research Site
Riverside, California, United States
Research Site
Sherman Oaks, California, United States
Research Site
Fort Lauderdale, Florida, United States
Research Site
Fort Myers, Florida, United States
Research Site
Gainsville, Florida, United States
Research Site
Hallandale, Florida, United States
Research Site
Jacksonville, Florida, United States
Research Site
Maitland, Florida, United States
Research Site
Orlando, Florida, United States
Research Site
St. Petersburg, Florida, United States
Research Site
Tampa, Florida, United States
Research Site
West Palm Beach, Florida, United States
Research Site
Atlanta, Georgia, United States
Research Site
Hoffman Estates, Illinois, United States
Research Site
Oak Brook, Illinois, United States
Research Site
Schaumburg, Illinois, United States
Research Site
Lafayette, Indiana, United States
Research Site
Terre Haute, Indiana, United States
Research Site
Shreveport, Louisiana, United States
Research Site
Glen Burnie, Maryland, United States
Research Site
Westminster, Maryland, United States
Research Site
Braintree, Massachusetts, United States
Research Site
Piscataway, New Jersey, United States
Research Site
Cedarhurst, New York, United States
Research Site
New York, New York, United States
Research Site
Staten Island, New York, United States
Research Site
Raleigh, North Carolina, United States
Research Site
Cincinnati, Ohio, United States
Research Site
Cleveland, Ohio, United States
Research Site
Dayton, Ohio, United States
Research Site
Willoughby, Ohio, United States
Research Site
Oklahoma City, Oklahoma, United States
Research Site
Eugene, Oregon, United States

11 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Dec 2008
Primary completion: 31 May 2009
Completion: 31 May 2009
Last update posted: 8 Oct 2010
Registered enrollment: 369
Registry id: NCT00807937

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.